Crime Opportunities Provided by Legislation in Market Sectors: Mobile Phones, Waste Disposal, Banking, Pharmaceuticals



Project Marc aims at developing a mechanism for assessing the risks of crime due to legislation and products in order to proof them against crime at EU level. Such a mechanism can only be developed on the basis of a true insight into the opportunities for crime provided by regulation. To gain such an insight, several market sectors were screened for their opportunities for crime and more specifically crime generated through the regulation of these market sectors. Case studies of four market sectors were carried out based on a literature scan and interviews with experts in the field. Risks created by the regulation of the market sectors are twofold: first, there are the risks for non-compliance with a specific regulation in the economic sector. This is the largest category and is created by problems inherent in the regulation itself. The second group of risks is the risk for side effects. Side effects occur when legislation is created with a certain purpose, but at the same time the legislation provides unwanted opportunities for crime. The risks created by the regulation may result in corruption, fraud, money laundering, infiltration of crime in the legal sector or other types of crime.

Key words

banking corruption crime proofing crime risk assessment mobile phones organised crime pharmaceutical waste disposal 



  1. Arfwedson, J. (2003). Parallel trade in pharmaceuticals. Centre for New Europe, 1. URL:
  2. Ananova (2004). Police Launch Mobile Phone Unit. URL:
  3. Bank of Credit and Commerce (2004). URL:
  4. BBC News UK Edition (2003). Mobile Phone Fraud Arrests. URL:
  5. Counterfeit drugs: guidelines for the development of measures to combat counterfeit drugs (1999). Wereldgezondheidsorganisatie. Genève, Switserland. p 16. URL:
  6. HM Customs and Excise (2004a). Two customs VAT fraud prosecutions send fraudsters to jail for 28 years. URL:
  7. Ferrigno, R. (2003). A case study on the implementation of EU environmental legislation. European Environmental Bureau. URL:
  8. Freudenberg, R. (2004). Counterfeit medicines. An excuse to smear parallel trade with no evidence, Pharmaceutical Journal, vol 273, No 7321 p560. URL:
  9. Frohlich, T. (2003). Organised environmental crime in a few candidate countries. URL:
  10. Gibson, L. (2004). Drug regulators study global treaty to tackle counterfeit drugs. URL:
  11. Illegal trafficking in hazardous waste in Italy and Spain (2003). Gruppo Abele, Legambiente. p 23 f.f.. URL:
  12. International Federation of Pharmaceutical Manufacturers Associations, Counterfeiting of Medicinal Products (1997). IMFA Position. URL:
  13. Lipman, Z. (2004). Trade in hazardous waste: environmental justice versus economic growth. URL:
  14. Maclean, N. (2004). Parallel trade in medicines, results of a social market foundation discussion seminar, p 18. URL:
  15. Management of Hazardous Wastes (1997). Pollution prevention and abatement handbook. World Bank. URL:
  16. Markoff, J. (1999). Researchers crack code in cell phones. URL:
  17. National Crime Squad (2004). New Trojan e-mail attack targets online banking customers. London: NCS. URL:
  18. National Crime Squad (2004). New Trojan e-mail attack targets online banking customers. London: NCS. URL:
  19. NCIS (2003). UK threat assessment - the threat from serious and organised crime 2003. London. URL:
  20. NCIS (2003). UK threat assessment of serious and organised crime 2003, URL:
  21. Pilgrim, R. (2003). BCCI claims dubbed ‘Hopelessly misconceived’ by Bank of England. URL:
  22. Pomeroy, R., & Reuters (2004). Italy faces waste ‘uprising’. URL:,,3772–3770151,00.html.
  23. Rapport IMPEL-TFS Seaport Project ’Illegal waste shipments to developing countries, common practice’ (2004). p 15. URL:
  24. Reuters (2004). Alarm over toxic pollution brings Mafia into focus. URL:
  25. Statement of GlaxoSmithKline on the Anti-Counterfeit Drug Initiative of the Food and Drug Administration (2003). URL:
  26. The Labour Party (2004). Law needed urgently to register mobile phones. URL:
  27. The Prescription Drug Marketing Act. Report to Congress, Department of Health and Human Services (2001). U.S. Food and Drug Administration. URL:
  28. The story behind Parmalat’s bankruptcy (2004), Executive Intelligence Review. URL:
  29. Transparancy International’s Report (2003). Clean money, dirty money: corruption and money laundering in the UK. Policy Research Paper 2. URL:
  30. United Kingdom Threat Assessment of Serious and Organised Crime (2003). NCIS. URL:
  31. Waste legislation: commission pursues legal action against 6 Member States (2004). Brussels. URL:
  32. CNN (2003). Britain Attacks soaring mobile phone theft. CNN. URL:
  33. Yates, C. (2003). Mobile phone issues - what risks are associated with their use by our youth?. URL:


  1. Briscoe, S. (2001). The problem of mobile phone theft. Crime and Justice Bulletin, 56.Google Scholar
  2. Clarke, R. V., et al. (2001). Controlling cell phone fraud in the US - lessons for foresight. Security Journal, 14 (1), 7–22.Google Scholar
  3. Clover, C. (2001). Fridge dumping, the nuisance that’s about to hit the street. The Daily Telegraph.Google Scholar
  4. Day, K., & O’hara, T. (2004). Executive at Riggs was bank’s examiner: vice president’s conduct as regulator under examination(p. E01). Washington Post.Google Scholar
  5. De Pauw, F. (2000). Italiaanse milieumaffia kent gouden tijden. De Standaard.Google Scholar
  6. Edmondson, G., & Carlisle, K. (2003). Italy and the eco-mafia. Business Week.Google Scholar
  7. Garattini, S., Bertele, V., & Li Bassi, L. (2003). Light and shade in proposed revision of EU drug-regulatory legislation, Lancet, 361.Google Scholar
  8. Horton, R. (2003). Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet, 364(9450), 1995–1996.CrossRefGoogle Scholar
  9. IPS (2005). Food and Drug Administration beschuldigd van ‘misleiding. De Morgen.Google Scholar
  10. Klein, T., & Rottenberg, H. (1998). Milieucriminelen werken gewoon op kantoor. De Volkskrant.Google Scholar
  11. Menzer, J. (2004). FDA’s counsel accused of being too close to drug industry. British Medical Journal, 329, 189.Google Scholar
  12. Newton, P., White, N., Roozendaal, J., & Green, M. (2002). Murder by fake drugs. British Medical Journal, 324(7341).Google Scholar
  13. VBR (2004). Pijnstiller Vioxx teruggetrokken. De Standaard.Google Scholar
  14. Wertheimer, A., Chaney, N., & Santella, T. (2003). Counterfeit pharmaceuticals: current status and future projections. Journal of the American Pharmaceutical Association, 43(6), 710–717.CrossRefGoogle Scholar
  15. De Standaard (2004). Farmabedrijven mogen parallelimport niet verbieden.Google Scholar
  16. British Pharmaceutical Conference (2003). Counterfeiting. Pharmaceutical Journal, 271(7269), 453–454.Google Scholar

Book and Papers

  1. Armitage, R., Pease, K., & Clarke, R. (2005). Analysis of the legitimate logistics and structures of organised crime at a European level: case studies (mobile phone sector), unpublished. University College of London, Jill Dando Institute of crime Science.Google Scholar
  2. Dempsey, G. (2003). The changing face of fraud: phone fraud: paper presented at the 3rd National Outlook Symposium on Crime in Australia. Canberra: Australian Institute of Criminology.Google Scholar
  3. Dorn, N., & Levi, M. (2004). Offshore banking regulation: case studies, interviews, select bibliography, November, internal project note, unpublished, 25 pp.Google Scholar
  4. Scarpiti, F., & Block, A. (1987). America’s toxic waste racket: dimensions of the environmental crisis. In S. Timothy & S. Bynum (Eds)., Organized crime in America: concepts and controversies (p. 149). Money: Willow Tree Press.Google Scholar
  5. Van Den Anker, M. (1999). Wie betaalt, bepaalt: over intermediaire organisaties, milieucriminaliteit, organisatiecriminaliteit en integriteit in het complexe milieuveld. ’s-Gravenhage: Elsevier bedrijfsinformatie.Google Scholar
  6. Van Den Berg, E. (1996). Grote strafrechtelijke milieu-onderzoeken. Den Haag: Ministerie van justitie, WODC.Google Scholar
  7. Vander Beken, T., & Balcaen, A. (2005). Analysis of the legitimate logistics and structures of organised crime at a European level: case studies (pharmaceutical sector), unpublished. Ghent University, Institute for International Research on Criminal Policy. Ghent, Belgium.Google Scholar
  8. Van Traa Commissie (1996). Enquêtecommissie opsporingsmethoden. Bijlage IX, Deelonderzoek 2, branches. ’s-Gravenhage: SDU Uitgevers.Google Scholar
  9. Report of the Food and Drug Administration (2004). Combating Counterfeit Drugs.Google Scholar

Copyright information

© Springer Science + Business Media B.V. 2006

Authors and Affiliations

  1. 1.Institute for International Research on Criminal PolicyGhent UniversityGentBelgium

Personalised recommendations